Centene shares plummet after Trump victory | St. Louis Post-Dispatch
The future of healthcare policies that have benefited Centene Corp. are now uncertain with the election of Donald Trump — and investors reacted strongly on Wednesday.
Social networking by doctors may save patients' lives, study suggests | ScienceDaily
Heart surgery patients' chances of survival depends in part on the overall previous level of teamwork among all the physicians who cared for them across their surgery preparation, operation, hospitalization and recuperation, research indicates.
Alabama leaders say Trump presidency gives them more control over Medicaid | (Florence, Ala.) Times Daily
Some state lawmakers said this morning that Donald Trump's presidency will give the state more flexibility with its largest General Fund expense — Medicaid.
Departing hospitals chief took 52 out-of-state trips in brief tenure | New York Post
Departing municipal-hospitals President Dr. Ram Raju took 52 out-of-state trips in the two years and eight months he ran the system — including for all or part of 78 workdays, according to records obtained by The Post.
Texas hospital attacked by hackers, patient lab data accessed | D Healthcare Daily
Denton, Texas-based Integrity Transitional Hospital announced this week that it was the victim of a security breach that may have allowed hackers to see the results of lab tests, health insurance data, and driver's licenses associated with patients that visited the lab.
U.S. watchdog told Medicare, Medicaid that EpiPen was misclassified in 2009: senator | Reuters
The internal watchdog at HHS warned the office tasked with administering federal health insurance programs that Mylan's EpiPen was improperly classified as a generic drug in 2009, Sen. Chuck Grassley said on Tuesday.
Valeant plunges again, warning 'could still be surprises' | Bloomberg.com
After an already tumultuous year, Valeant Pharmaceuticals International once again took investors off guard as the new management cut the annual profit forecast to well below estimates and suggested there may be more bad news on the way.
CVS says slowing prescriptions will hurt profits next year | Bloomberg.com
CVS Health Corp.'s earnings forecasts for 2016 and 2017 came in below analysts' estimates as the company said its drugstores will lose millions of prescriptions, sending the shares plunging Tuesday to their biggest daily loss in seven years.
